News

$10m funding accelerates innovation and growth for EchoGo

Artificial intelligence (AI) health-tech company Ultromics announced today it has  closed a $10 million financing round to accelerate its next stage of business growth. The capital has been raised …

Off-cart analysis and diagnosis can enhance workflow efficiencies and reduce exposure to COVID

Healthcare systems are accustomed to adapting to change, but the current COVID-19 crisis is unique. Whilst many past changes to healthcare delivery have allowed for technology adoption over time …

Ultromics collaborates with Mayo Clinic to optimize the impact of AI tools on care pathways

Ultromics, a health-tech company which applies AI to echocardiography, to earlier detect and better diagnose heart disease, has entered a know-how and clinical research agreement with Mayo Clinic. Underpinned …

New Strain code is first Echo technology to get Medicare reimbursement in over a decade

As of January 1 2020, cardiologists in the United States can now report and bill for myocardial strain imaging using the new Category 1 CPT code +93356. The policy …

Mayo Clinic collaborates with Ultromics to rapidly assess patients diagnosed with COVID-19

Collaboration between Ultromics and Mayo Clinic aims to quantify cardiac involvement in COVID-19 and help triage high-risk patients with myocardial injury A joint UK-US research team is applying a …

Ultromics CE mark’s AI system EchoGo Pro

The AI technology can be used for the first time to accurately and instantly predict heart disease risk through non-invasive, ultrasound analysis. This is the primary imaging test to …

Cardiac disease in pregnancy: how AI technology can help midwives with frontline detection

The theme of this year’s World Health Day (April 7th) is to recognise the work of nurses and midwives and remind world leaders of the critical role they play …

Ultromics achieves ISO 27001 certification

  Ultromics has received ISO 27001 certification. The standard recognises our commitment to data security and ensures, for patients, clinicians and healthcare providers, that personal healthcare information and other …

Ultromics receives FDA clearance

  Ultromics receives FDA clearance for its AI-powered decision support system, EchoGo Core.   AI automates cardiac analysis helping earlier detection of cardiovascular disease, enabling clinicians to improve patient …

Ultromics secures £10 million investment to bring AI heart diagnostics to hospitals

Ultromics, the UK start-up behind breakthrough artificial intelligence (AI) technology for the diagnosis of coronary heart disease, has raised £10 million in Series-A investment. The funding was led by …

Ultromics secures additional £1m investment from Woodford Investment Management

Ultromics is excited to announce our latest investor, Woodford Investment Management, who have added £1m to our recently closed £10m Series A round. Woodford Investment Management joins a group …

Artificial intelligence to diagnose heart disease

AI early diagnosis could save heart and cancer patients

Ultromics CEO Ross Upton was interviewed on BBC

Ultromics AI platform to expand trials to 20 NHS hospitals

Artificial intelligence will improve medical treatments

The young biotech entrepreneurs bringing grey hair into the C-suite

Start-ups leveraging AI to improve outcomes and put patients in control of their care

Ultromics expands coronary artery disease trials to the U.S.

Ultromics expands coronary artery disease trials to the U.S. to establish largest ongoing clinical trial programme of its kind UK start-up behind breakthrough artificial intelligence (AI) technology for the …

Ultromics becomes founding partner of AI centre of excellence

Top 10 advancements in health around the world thanks to AI

AI in cardiovascular health

Ultromics founder awarded Forbes 30 Under 30 Europe Science & Healthcare

10 amazing European AI start-ups to watch

How will artificial intelligence impact healthcare?

*Pending FDA 510(k) clearance, not available for sale in the United States, not CE-marked

**CAUTION–Investigational device. Limited by Federal (or United States) law to investigational use